| Nov 19 |
US Penny Stocks To Watch In November 2024
|
| Nov 19 |
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
|
| Nov 14 |
Achilles Therapeutics GAAP EPS of -$0.48
|
| Nov 14 |
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
|
| Sep 23 |
Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?
|
| Aug 14 |
Achilles Therapeutics GAAP EPS of -$0.41
|
| Aug 14 |
Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?
|
| Aug 14 |
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
|
| May 22 |
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
|
